RCS - Tristel PLC - Study shows Tristel Wipes System benefits <Origin Href="QuoteRef">TSTL.L</Origin>

TristelAnnouncement

12/10/2016 08:15

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20161011:nRSK1596Ma


RNS Number : 3198M
Tristel PLC
12 October 2016 
 
Tristel plc 
 
("Tristel" or "the Company") 
 
Comparison of high-level disinfectants for flexible nasendoscopes published
in 
 
The Journal of Laryngology & Otology 
 
Tristel plc (AIM: TSTL), the manufacturer of infection prevention,
contamination control and hygiene products, announces that in a randomised,
single-blind comparison of disinfectants used in Ear, Nose and Throat clinics,
its Wipes System proved to be the equal in terms of microbiological efficacy
to disinfectants produced by Du Pont and Johnson & Johnson. In the study Du
Pont's PeraSafe peracetic acid disinfectant was used in a tray, and Johnson &
Johnson's Cidex OPA ortho phthalaldehyde disinfectant was used in an automated
washer-disinfector manufactured by Medvators Inc. The Tristel Wipes System is
a stand-alone process requiring no equipment, support building services, or
maintenance. The study concluded that the Wipes System has no capital outlay
cost, the lowest running cost, the greatest convenience, and the fastest
turnaround time for medical instruments of the three products evaluated. 
 
The study, which was conducted by the Bay of Plenty District Health Board,
Tauranga, New Zealand in 2011 has been published in the The Journal of
Laryngology & Otology [Hitchcock, B., Moynan, S., Frampton, C., Reuther, R.,
Gilling, P. and Rowe, F. (2016) 'A randomised, single-blind comparison of
high-level disinfectants for flexible nasendoscopes', The Journal of
Laryngology Otology, pp. 1-7. doi: 10.1017/S0022215116008860].  Preliminary
results of the study were presented at the 11th Congress for German Hospital
Hygiene held in Berlin in March 2012, and reported by an RNS Reach on 29 March
2012. 
 
The Tristel Wipes System is a unique, patented decontamination method for
non-lumened scopes and probes. It has been a very significant sales success
for the Company globally. Worldwide sales in the financial year ending June
2012 were £3.3m and are expected to be £8.7m in the year ending June 2016. 
 
Paul Swinney, CEO, comments:"We are pleased to see at long last the
publication in a peer-reviewed journal of this significant study comparing our
Wipes System with competitor products manufactured by two of the world's major
infection prevention companies. The results affirm the key advantages of our
Wipes over alternative chemistries and disinfection methods. This is the
twenty-fifth peer-reviewed and published scientific paper featuring Tristel
products - a body of evidence of our products' attributes that forms one of
our Company's key strengths." 
 
For further information please contact: 
 
 Tristel plc                                  Tel: 01638 721 500                            
 Paul Swinney, Chief Executive Officer                                                      
 Liz Dixon, Finance Director                                                                
                                                                                            
 Walbrook PR Ltd                              Tel: 020 7933 8780 or tristel@walbrookpr.com  
 Paul McManus                                 Mob: 07980 541 893                            
 Lianne Cawthorne                             Mob: 07584 391 303                            
                                                                                            
 finnCap                                      Tel: 020 7600 1658                            
 Geoff Nash/ Giles Rolls (Corporate Finance)                                                
 Stephen Norcross (Corporate Broking)                                                       
                                                                                              
 
 
This information is provided by RNS
The company news service from the London Stock Exchange